Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE -- Ignore unavailable to you. Want to Upgrade?

To: bvortex who wrote (638)	7/27/2000 9:05:57 AM
From: Susan Saline	Read Replies (1) \| Respond to of 670

finally a bit of pretty interesting news ... Thu Jul 27 PRCY.OB ProCyte Expands Skin & Hair Distribution With Biopharm Group International; Thinning Hair Products Promising for Middle East Markets - PR Newswire biz.yahoo.com REDMOND, Wash., July 27 /PRNewswire/ -- ProCyte Corporation (OTC Bulletin Board: PRCY - news), a leading skin health, hair care and wound care company, today announced a signed distribution agreement with BioPharm Group International, a leading Egyptian biotech company for 10 countries in the Middle East, including Saudi Arabia. The agreement allows ProCyte products containing its patented copper peptide technology for skin care and hair care to be available in the Middle Eastern dermatology and plastic surgery markets. Initial product launches are expected in late 2000 or early 2001 in Saudi Arabia and Egypt with Tricomin® advanced hair care and Complex Cu3(TM) intensive repair products. Tricomin® line of hair care products contain the patented Triamino Copper Nutritional Complex(TM) designed specifically for the maintenance of thinning hair in men and women. The Tricomin® Solution Follicle Therapy Spray, along with the Tricomin® Shampoo and Tricomin® Conditioner, deliver copper with amino acids for nourishing and stimulating the hair and scalp for improved health, strength, and appearance. The Complex Cu3(TM) System consists of the Complex Cu3(TM) Intensive Repair Creme that has been used to treat patients following chemical peels, dermabrasion and laser treatment. Inclusive with the line is also the Complex Cu3(TM) hydrating Gel and Complex Cu3(TM) Gentle Cleanser that provide a comprehensive approach to post-procedure care. ``We are continuing to expand our product sales into the international markets,'' said Jack Clifford, ProCyte Chairman and CEO. ``By selecting dynamic, strategic partners who are well positioned in their own sector, we are able to cost effectively penetrate new markets. We are looking forward to our new alliance.'' About ProCyte: ProCyte Corporation is a healthcare products company that develops and markets products for skin health, hair care and wound care. ProCyte's products include a comprehensive therapeutic skin care line including products for post-laser treatment and anti-aging applications, as well as products for thinning hair. Products incorporate ProCyte's patented, clinically proven copper peptide technology, which are marketed both directly and through distribution partners. This report may contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those projected. This report should be read in conjunction with the Company's annual report on Form 10-K and it's quarterly reports on Form 10-Q. The Company's results may vary significantly from quarter to quarter and will depend, among other factors, on product launches and market acceptance, manufacturing contracts, and distribution agreements. For more information, contact: Jack Clifford, Chairman/CEO of ProCyte Corporation, 425-869-1239; or Michael S. Manahan, Principal of Magnum Financial Group, LLC, 213-488-0443, for ProCyte Corporation. SOURCE: ProCyte Corporation